HealthyDirect · GrowthFit for a long SIP
Invesco India Multi Asset Allocation Fund
Invesco Mutual FundHybrid Schemes - Multi Asset Allocation Fund1.9 years
The scheme seeks to generate long-term capital appreciation/income from an actively managed portfolio of multiple asset classes.
- NAV
- 12.27
- 29 Oct 2026
- 1Y
- +5.1%
- Trailing CAGR
- AUM
- ₹1,233.72 Cr
- 31 Aug 2026
- Volatility
- Medium
- 9.8% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 98% of rolling 1-year windows.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Fail
1.9 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.54% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -11.0%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Amey Sathe · 1.0 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 53.6% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 11%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+5.1%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+12.3%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-1.5%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +12.3%
- Calendar-day CAGR
- Excess 1Y
- +2.6%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -11.0%
- Worst peak-to-trough
- Current
- -5.8%
- Below last peak
- Current spell
- 65 days
- Days below latest peak
- Time below peak
- +76%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 9 days
- 39 recovered episodes
- Longest recovery
- 155 days
- Trough to prior peak
29 Jan 2026 – 25 Aug 2026
Trough 23 Mar 2026 · recovered in 155 days
-11.0%
25 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-6.8%
2 Apr 2025 – 16 Apr 2025
Trough 7 Apr 2025 · recovered in 9 days
-4.4%
7 Feb 2025 – 24 Mar 2025
Trough 28 Feb 2025 · recovered in 24 days
-3.0%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
34
Vs category
66
Consistency
98
Risk-adjusted
58
Drawdown
73
Mean
66
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 98% of rolling 1-year windows.
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
31 Aug 2026 · 95 holdings · top 10 are 53.6%.
- Top 5
- 39.5%
- Top 10
- 53.6%
- Largest holding
- 13.7%
- Effective holdings
- 20.6
Invesco India Gold ETF
Unspecified
13.7%
Invesco US Value Equity Fund - C Acc Shares
Unspecified
11.9%
ICICI Prudential Midcap 150 ETF - Growth
Unspecified
5.0%
Mirae Asset Nifty Midcap 150 ETF Regular - Growth
Unspecified
5.0%
HDFC Bank Ltd
Financial
4.0%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
DSP Multi Asset Allocation Fund
DSP Mutual Fund
- 1Y
- +4.2%
- 3Y
- +17.3%
- Vol
- 8.9%
- Max DD
- -9.7%
- Sharpe
- 1.27
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher TER
WhiteOak Capital Multi Asset Allocation Fund
WhiteOak Capital Mutual Fund
- 1Y
- +6.0%
- 3Y
- +16.1%
- Vol
- 5.6%
- Max DD
- -6.1%
- Sharpe
- 1.58
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher TER
360 ONE Multi Asset Allocation Fund
360 ONE Mutual Fund
- 1Y
- +8.3%
- 3Y
- n/a
- Vol
- 12.0%
- Max DD
- -9.9%
- Sharpe
- 0.84
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Higher TER
HDFC Multi Asset Allocation Fund
HDFC Mutual Fund
- 1Y
- -2.6%
- 3Y
- +11.1%
- Vol
- 8.0%
- Max DD
- -27.1%
- Sharpe
- 0.65
- 3Y win
- +44%
- Lower volatility
- Higher trailing returns
Caveat: Deeper drawdown · Higher TER
Mahindra Manulife Multi Asset Allocation Fund
Mahindra Manulife Mutual Fund
- 1Y
- +3.9%
- 3Y
- n/a
- Vol
- 9.0%
- Max DD
- -9.5%
- Sharpe
- 0.81
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns